phloroglucinol has been researched along with Prostatic Hyperplasia in 1 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect and safety of phloroglucinol combined with parecoxib on cystospasm after transurethral resection of the prostate (TURP)." | 9.22 | [Phloroglucinol combined with parecoxib for cystospasm after transurethral resection of the prostate]. ( Cheng, SH; Ding, M; He, HT; Hu, SB; Li, L; Nian, YQ; Wang, YH, 2016) |
| "To evaluate the effect and safety of phloroglucinol combined with parecoxib on cystospasm after transurethral resection of the prostate (TURP)." | 5.22 | [Phloroglucinol combined with parecoxib for cystospasm after transurethral resection of the prostate]. ( Cheng, SH; Ding, M; He, HT; Hu, SB; Li, L; Nian, YQ; Wang, YH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, SH | 1 |
| Nian, YQ | 1 |
| Ding, M | 1 |
| Hu, SB | 1 |
| He, HT | 1 |
| Li, L | 1 |
| Wang, YH | 1 |
1 trial available for phloroglucinol and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Phloroglucinol combined with parecoxib for cystospasm after transurethral resection of the prostate].
Topics: Aged; Case-Control Studies; Drug Therapy, Combination; Humans; Isoxazoles; Length of Stay; Male; Mid | 2016 |